ADAMTS13 and thrombotic thrombocytopenic purpura: The majority of TTP patients (∼95%) suffer from acquired TTP caused by the presence of inhibitory and/or clearance-inducing anti-ADAMTS13 autoantibodies (autoAbs) [10,11].